Rethinking Uncomplicated UTIs: A Comprehensive Review of Diagnosis, Management, and Novel and Emerging Treatment Options
Resource Tool
Before entering the activity, please download this clinical resource tool to guide your decision making throughout the assessment and treatment process.
Released On
April 14, 2025
Expires On
April 14, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Primary Care, Urology
Topic(s)
UTI
This activity is provided by Global Education Group and Iridium Continuing Education.
This activity is supported by an independent education grant from GSK.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Nursing Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of primary care physicians, physician assistants, nurse practitioners, nurses and other healthcare professionals in primary care.
Program Overview
The high prevalence and significant personal and healthcare impact and the advancements in UTI management highlight the importance of accurate diagnosis, streamlined treatment protocols, and optimizing patient care.
HCPs must remain familiar with the classification of UTIs, the common signs and symptoms of uncomplicated UTIs, readily available diagnostic tools, and appropriate antibiotic selection based on local resistance patterns. Furthermore, staying updated on evolving antibiotic resistance trends and the potential need for alternative therapies is crucial.
Effective management also requires clear communication and collaboration within healthcare teams to ensure optimal patient outcomes. This includes providing standardized education and support for patients to understand their condition, treatment options, and preventative measures.
By focusing on these collective efforts, we can ensure the best possible care for patients with uncomplicated UTIs and minimize the risk of complications. In this program, learners will explore these topics with Dr. Jennifer Anger and then meet with an AI Patient, Allie, and apply their knowledge.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- APPLY evidence-based guidelines to accurately interpret signs, symptoms, and laboratory test results for diagnosing uUTIs.
- UTILIZE evidence-based guidelines in selecting antimicrobial therapy for uncomplicated UTIs, thereby minimizing unnecessary antibiotic use.
- REVIEW the key factors contributing to treatment failure in patients with uncomplicated urinary tract infections.
- EVALUATE the impact of uUTI and treatment failure on patient well-being.
- INTEGRATE patient education and shared decision-making into their management of uUTIs.
Faculty
Jennifer Anger, MD, MPH
Professor and Vice Chair of Research
C. Lowell and JoEllen Parsons Endowed Chair in Urology
Diplomate, American Board of Urology
Gender Affirming Surgery, Urologic Reconstruction and FPMRS
UC San Diego Department of Urology
San Diego, CA
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Physician Credit Designation Statement
Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Relevant Financial Relationship(s)
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Jennifer Anger, MD, MPH
- Nothing to disclose
Matt T. Rosenberg, MD (Reviewer)
- Nothing to disclose
Global
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
Iridium
The planners and managers at Iridium have no relevant financial relationships to disclose.
Instructions for Participation and Credit
This activity should be completed on a computer. There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Complete the pretest.
- Participate in the online activity.
- Complete the posttest with a score of 70% or higher.
- Submit the evaluation form.
Certificates will be available for download to the participant.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Iridium do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For CME questions, please contact [email protected] or [email protected].
Resource Tool
Before entering the activity, please download this clinical resource tool to guide your decision making throughout the assessment and treatment process.